These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38636168)

  • 21. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected].
    Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J
    Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum anti-Müllerian hormone levels are associated with low bone mineral density in premenopausal women.
    Yan Y; Chen W; Wang J; Huang J; Lv J; Zhao H; Guo L
    Biomarkers; 2020 Dec; 25(8):693-700. PubMed ID: 33025829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of serum osteocalcin with bone microarchitecture and muscle mass in Beijing community-dwelling postmenopausal women.
    Liu S; Pang Q; Guan W; Yu F; Wang O; Li M; Xing X; Yu W; Jiang Y; Xia W
    Endocrine; 2024 Apr; 84(1):236-244. PubMed ID: 38206435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced serum levels of anti-Mullerian hormone is a putative biomarker of early knee osteoarthritis in middle-aged females at menopausal transition.
    Sasaki E; Chiba D; Ota S; Kimura Y; Sasaki S; Yamamoto Y; Oishi M; Iino K; Ando M; Tsuda E; Ishibashi Y
    Sci Rep; 2021 Mar; 11(1):4931. PubMed ID: 33654174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty.
    Coutant R; Biette-Demeneix E; Bouvattier C; Bouhours-Nouet N; Gatelais F; Dufresne S; Rouleau S; Lahlou N
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5225-32. PubMed ID: 20826577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.
    Soto N; Iñiguez G; López P; Larenas G; Mujica V; Rey RA; Codner E
    Hum Reprod; 2009 Nov; 24(11):2838-44. PubMed ID: 19643804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women.
    Atalay S; Elci A; Kayadibi H; Onder CB; Aka N
    Ann Lab Med; 2012 Jan; 32(1):23-30. PubMed ID: 22259775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibin B and anti-Müllerian hormone, but not testosterone levels, are normal in infants with nonmosaic Klinefelter syndrome.
    Lahlou N; Fennoy I; Carel JC; Roger M
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1864-8. PubMed ID: 15070957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum kisspeptin, neurokinin B and inhibin B levels can be used as alternative parameters to distinguish idiopathic CPP from premature thelarche in the early stages of puberty.
    Vuralli D; Ciftci N; Demirbilek H
    Clin Endocrinol (Oxf); 2023 Jun; 98(6):788-795. PubMed ID: 36879296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of age and menopausal stage on serum anti-Müllerian hormone levels in middle-aged women.
    Zhang J; Wang X; Ren Z; Shao S; Hou Z; Wang Z; Xi J; Bai W
    Climacteric; 2021 Dec; 24(6):618-623. PubMed ID: 34427163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B.
    Färkkilä A; Koskela S; Bryk S; Alfthan H; Bützow R; Leminen A; Puistola U; Tapanainen JS; Heikinheimo M; Anttonen M; Unkila-Kallio L
    Int J Cancer; 2015 Oct; 137(7):1661-71. PubMed ID: 25808251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum INHB levels and ACE gene I/D polymorphism with increased risk for unexplained infertility.
    Turan T; Pekel A; Duvan ZCI; Gönenç A
    J Biochem; 2021 Oct; 170(2):245-253. PubMed ID: 33768251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.
    Reginster JY; Sarkar S; Zegels B; Henrotin Y; Bruyere O; Agnusdei D; Collette J
    Bone; 2004 Feb; 34(2):344-51. PubMed ID: 14962813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Sertoli cell hormones inhibin-B and anti Müllerian hormone have different patterns of secretion in prepubertal cryptorchid boys.
    Cortes D; Clasen-Linde E; Hutson JM; Li R; Thorup J
    J Pediatr Surg; 2016 Mar; 51(3):475-80. PubMed ID: 26452703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
    Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
    Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.
    Bry-Gauillard H; Larrat-Ledoux F; Levaillant JM; Massin N; Maione L; Beau I; Binart N; Chanson P; Brailly-Tabard S; Hall JE; Young J
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1102-1111. PubMed ID: 28324034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibin B and anti-Müllerian hormone/Müllerian-inhibiting substance may contribute to the male bias in autism.
    Pankhurst MW; McLennan IS
    Transl Psychiatry; 2012 Aug; 2(8):e148. PubMed ID: 22872163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy.
    Fink E; Cormier C; Steinmetz P; Kindermans C; Le Bouc Y; Souberbielle JC
    Osteoporos Int; 2000; 11(4):295-303. PubMed ID: 10928218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.